Glucose-6-Phosphate Dehydrogenase (G6PD), Screen
Glucose-6-Phosphate Dehydrogenase (G6PD) is an enzyme involved in generating reduced glutathione and NADPH, which protects hemoglobin from oxidative denaturation. It is present in many types of cells, but is especially important in the red blood cell. G6PD has been considered a housekeeping gene protecting the red blood cells from oxidative damage. A deficiency of G6PD can lead to the destruction of red blood cells through the process of hemolysis; this may occur when the body is exposed to certain drugs or the stress of infection. Some individuals can have hemolytic episodes when exposed to fava beans or inhalation. When the body cannot compensate for the destruction of RBCs, anemia is the result. G6PD-induced hemolysis is associated with Heinz bodies, poikilocytes, and occasional spherocytes noted on the peripheral smear. There are over 440 different mutations of G6PD isoenzymes. Of these the G6PD-A(+) isoenzymes and G6PD-A(–) are most significant in the African-American population since 10% to 15% carry the variant. Some Mediterranean people have the B– variant that has an extremely low enzyme activity. G6PD deficiency is an X-linked recessive disease which means it can be passed on from either parent.
The World Health Organization has sub-classed the 440 plus isoenzymes into four separate classes based on severity of the disease from Severe Enzyme Deficiency to No Enzyme Deficiency.
- Class I, severe enzyme deficiency with chronic hemolytic anemia (<10% of normal enzyme activity)
- Class II, severe enzyme deficiency with intermediate hemolytic anemia
- Class III moderate to severe enzyme deficiency with mild to moderate hemolytic anemia
- Class IV is a normal phenotype with no enzyme deficiency and no hemolytic anemia
Since this is an X-linked recessive disorder, partial expression can be found in females who are heterozygous for the gene; these individuals will show a dual population of red blood cells, one normal and one deficient.
- Screening for drug sensitive G6PD deficiency
- As an aid in diagnosis of hemolytic anemias
- Differential diagnosis of red blood cell hemolysis
Increased in:
- Increased erythrocyte production due to related proliferative disorders (Marked Reticulocytosis).
Note: false normal results may be obtained after hemolytic episodes; therefore testing may need to be repeated if the result is normal and the anemia continues without a known cause.
Decreased in:
- G6PD deficiency
G6PD Enzyme Activity Detected (5–14 IU/g Hb)
Whole Blood EDTA (Lavender) or ACD (Yellow).
Stability
- Ambient: 48 hours
- Refrigerated: 7 days
- Frozen: Unacceptable
- Am Fam Physician. 2004;69:2599. [PMID: 15202694]
- Semin Perinatol. 2004 Oct;28(5):356-64. [PMID: 15686267]
- Am Fam Physician. 2005;72:1277. [PMID: 16225031]
- Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).